"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 9 | 9 |
| 2000 | 0 | 7 | 7 |
| 2001 | 0 | 4 | 4 |
| 2002 | 0 | 8 | 8 |
| 2003 | 0 | 15 | 15 |
| 2004 | 0 | 16 | 16 |
| 2005 | 1 | 27 | 28 |
| 2006 | 0 | 28 | 28 |
| 2007 | 0 | 38 | 38 |
| 2008 | 0 | 24 | 24 |
| 2009 | 0 | 34 | 34 |
| 2010 | 1 | 37 | 38 |
| 2011 | 3 | 45 | 48 |
| 2012 | 2 | 32 | 34 |
| 2013 | 4 | 47 | 51 |
| 2014 | 4 | 38 | 42 |
| 2015 | 4 | 53 | 57 |
| 2016 | 0 | 37 | 37 |
| 2017 | 5 | 59 | 64 |
| 2018 | 7 | 33 | 40 |
| 2019 | 4 | 30 | 34 |
| 2020 | 1 | 28 | 29 |
| 2021 | 4 | 19 | 23 |
| 2022 | 0 | 8 | 8 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Congenital Cutaneous Candidiasis in Preterm Infants. Neoreviews. 2023 03 01; 24(3):e175-e180.
-
The role of dietary factors in nonalcoholic fatty liver disease to hepatocellular carcinoma progression: A systematic review. Clin Nutr. 2022 10; 41(10):2295-2307.
-
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Ann Rheum Dis. 2022 11; 81(11):1541-1548.
-
Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial. Gynecol Oncol. 2022 09; 166(3):494-502.
-
Job Retention Among Individuals With Multiple Sclerosis: Relationship With Prediagnostic Employment and Education; Demographic Characteristics; and Disease Course, Severity, and Complications. Arch Phys Med Rehabil. 2022 Dec; 103(12):2355-2361.
-
Three-Month FVC Change: A Trial Endpoint for Idiopathic Pulmonary Fibrosis Based on Individual Participant Data Meta-analysis. Am J Respir Crit Care Med. 2022 04 15; 205(8):936-948.
-
The paradigm shift from NAFLD to MAFLD: A global primary care viewpoint. Liver Int. 2022 06; 42(6):1259-1267.
-
A Role of Complement in the Pathogenic Sequelae of Mouse Neonatal Germinal Matrix Hemorrhage. Int J Mol Sci. 2022 Mar 09; 23(6).
-
A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach. J Alzheimers Dis. 2022; 86(2):511-524.
-
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment. Am J Respir Crit Care Med. 2021 12 01; 204(11):1295-1305.